ThursdaySep 23, 2021 11:04 am

QualityStocksNewsBreaks – Tingo Inc. (IWBB) Names New Board Cochairs

Tingo (OTC: IWBB) has strengthened its already strong board of directors with the appointment of two new cochairs: John J. Brown and Christophe Francois Charlier.The two men bring impressive global experience to their new roles and represent a strategic move for the company as it works to list its shares on a national securities exchange such as the New York Stock Exchange. Named as independent cochair, Brown has served as managing partner of Sands Point Consulting LLC as well as an advisor to an array of entrepreneurs, founders and senior corporate leaders to assist and support in developing new business strategies…

Continue Reading

ThursdaySep 23, 2021 10:31 am

QualityStocksNewsBreaks – Delic Holdings Inc. (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0) Reiterates Engaging Lineup for Its Two-Day Immersive Edutainment Experience – Meet Delic

Delic Holdings (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0), the leading psychedelic wellness platform, today reiterated the full lineup of thought leaders, entrepreneurs, medical experts and entertainers taking part at its two-day premier Meet Delic psychedelics event. The experiential event will feature dancers, music, 3D mapping, new technologies and research, thought-provoking presentations and the world’s largest psychedelic business expo. The update includes a complete list of innovators slated to keynote, serve on panels and entertain for the event taking place from Nov. 6-7, 2021, at AREA15, an immersive and experiential venue in Las Vegas. To view the full press release, visit https://ibn.fm/x4ZZn About Delic…

Continue Reading

ThursdaySep 23, 2021 9:54 am

QualityStocksNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Forms Medical Consortium to Advance OSA Technology

Vivos Therapeutics (NASDAQ: VVOS), a medical technology company focused on developing and commercializing innovative treatments for patients suffering from sleep-disordered breathing, including mild to moderate obstructive sleep apnea (“OSA”), today announced the official formation of the Vivos Medical Consortium. According to the update, this physician working group, led by Drs. Clete Kushida of Stanford University and Cecilia Wu of the University of Alberta, will collaborate to advance Vivos’ OSA technology capabilities. “Every specialty in medicine deals with the negative impact of obstructive sleep apnea in some way, with the end stage of untreated sleep apnea including diminished quality of life,…

Continue Reading

WednesdaySep 22, 2021 3:43 pm

QualityStocksNewsBreaks – Golden Triangle Ventures Inc. (GTVH), Positron Partner to Tap into Lucrative Virtual Reality Events Space

Golden Triangle Ventures (OTC: GTVH) has partnered with Positron, a leading virtual reality (“VR”) technology and entertainment company, in a five-year agreement that places it in a strong position in the VR event space. Online pay-per-view performances became an option for artists to eke out a living following the pandemic-imposed restrictions. However, a recent article, which contains excerpts from a Forbes publication, notes that GTVH believes the real promise is in VR concerts, effectively agreeing with the Forbes piece. “Virtual reality concerts, although less common than online pay-per-view concerts, are potentially much more lucrative,” reads the article. Positron’s platform, developed…

Continue Reading

WednesdaySep 22, 2021 3:22 pm

QualityStocksNewsBreaks – Avricore Health Inc. (TSX.V: AVCR) (OTCQB: AVCRF) Is Revolutionizing Pharmacy Practice Through HealthTab(TM) Platform

Avricore Health (TSX.V: AVCR) (OTCQB: AVCRF) is disrupting and revolutionizing the pharmacy practice through its proprietary HealthTab(TM) solution, which sources the best point-of-care analyzers and brings them into a single, secure cloud-based network. A recent article quotes Avricore CEO Hector Bremner as saying, “The power of HealthTab is that it is able to greatly reduce the amount of administration time, extract the results directly out of the machine, merge information, do the complex calculations in order to properly interpret the data, and then produce it in an easy to read format that the patient and professional can interpret quickly and…

Continue Reading

WednesdaySep 22, 2021 3:15 pm

QualityStocksNewsBreaks – SRAX Inc. (NASDAQ: SRAX) Announces Unique Set of Safety Protocols for 2021 LD Micro Main Event

SRAX (NASDAQ: SRAX), a financial technology company that unlocks data and insights for publicly traded companies through Sequire, its software-as-a-service (“SaaS”) platform, today announced a unique set of safety protocols for the in-person component of the 2021 LD Micro Main Event on Oct. 12-14, 2021. Marking the first in-person conference for LD Micro in almost two years, the event brings physical and virtual elements together to form a truly unique experience. LD Micro announced that several presenting companies will also be providing their product, know-how and services to the in-person Main Event to ensure that everyone is safe and comfortable…

Continue Reading

WednesdaySep 22, 2021 2:40 pm

QualityStocksNewsBreaks – FuelPositive Corporation’s (TSX.V: NHHH) (OTCQB: NHHHF) Commissioned Study Shows Market for Green Ammonia in Canada

FuelPositive (TSX.V: NHHH) (OTCQB: NHHHF) recently announced the findings of a study it had commissioned in early 2021. Conducted by emissions reduction and carbon credit specialist Andre Mech, the study revealed that Canada generates sufficient green electricity today (hydroelectricity, solar and wind) during off-peak demand hours to produce enough carbon-free ammonia (“NH3”) to power 100% of the needs of passenger aviation, bus, and rail and freight aviation, trucks and marine transport. The study also revealed that the country produced enough off-peak green electricity to provide carbon-free NH3 fuel to power 63% of all passenger and freight vehicles, including motorcycles, rail,…

Continue Reading

WednesdaySep 22, 2021 2:21 pm

QualityStocksNewsBreaks – RYAH Group Inc. (CSE: RYAH) to Present at Wall Street Reporter’s ‘Next Super Stock’ Livestream Conference

RYAH Group (CSE: RYAH) today announced that its Chief Executive Officer Gregory Wagner will be presenting at Wall Street Reporter's "Next Super Stock" livestream conference on Thursday, Sept. 23, 2021. The online event is expected to give the investment community and existing shareholders an opportunity to interact in real time with Wagner and learn about the company and its operations. Wagner’s presentation is scheduled to begin at 1:00 ET on the day of the conference, during which he will highlight RYAH’s experience and mission, and, time permitting, open the floor for questions. Interested parties should visit https://ibn.fm/K0MtA to ensure access…

Continue Reading

WednesdaySep 22, 2021 2:14 pm

QualityStocksNewsBreaks – ISW Holdings Inc. (ISWH) Eyes Record Quarter in the Making Followed with Breakout Growth

ISW Holdings (OTC: ISWH) (transitioning to “BlockQuarry,” pending name change), a Nevada-based portfolio company with primary commercial-stage operations in cryptocurrency mining, today released an update to current and prospective shareholders on core performance metrics, timeframe for hosting deployment and corporate identity. Among the highlights, the company indicated that mining is fully underway in Pennsylvania, nearing full capacity on hashrate, and final adjustments and updates are being implemented into month end to push performance up to peak potential. The company anticipates a record quarter for the three months ending Sept. 30, 2021. In addition, ISWH expects and a much more significant…

Continue Reading

WednesdaySep 22, 2021 2:03 pm

QualityStocksNewsBreaks – Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Announces Submission of IND Application for Eating Disorders Clinical Trial

Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF), a pharmaceutical company focused on developing psilocybin-based compounds for diseases with unmet medical needs, has submitted an Investigational New Drug ("IND") application to the U.S. Food and Drug Administration ("FDA"). The clinical trial is designed to evaluate the efficacy of TRYP’s clinical candidate, TRP-8802, for the treatment of patients with eating disorders. TRYP is working with Jennifer Miller, MD, from the University of Florida, to conduct the trial as well as evaluate its oral formulation of synthetic psilocybin, TRP-8802, in combination with psychotherapy. The IND application outlines specifics in regard to the safety of…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered